UK markets close in 24 minutes

Transgene SA (0OCQ.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
1.4800-0.0080 (-0.54%)
As of 10:21AM BST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-47.43%
S&P500 52-week change 321.83%
52-week high 32.2950
52-week low 30.0000
50-day moving average 31.5842
200-day moving average 31.7158

Share statistics

Avg vol (3-month) 3520
Avg vol (10-day) 3543
Shares outstanding 562.28M
Implied shares outstanding 6N/A
Float 835.36M
% held by insiders 165.55%
% held by institutions 11.89%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -282.63%
Operating margin (ttm)-469.05%

Management effectiveness

Return on assets (ttm)-33.64%
Return on equity (ttm)-83.54%

Income statement

Revenue (ttm)7.9M
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)-24.30%
Gross profit (ttm)N/A
EBITDA -28.48M
Net income avi to common (ttm)-22.33M
Diluted EPS (ttm)-0.2140
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.67M
Total cash per share (mrq)0.15
Total debt (mrq)17.3M
Total debt/equity (mrq)110.78%
Current ratio (mrq)1.79
Book value per share (mrq)0.15

Cash flow statement

Operating cash flow (ttm)-34.67M
Levered free cash flow (ttm)-5.41M